Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities U.S. losartan market totals $256M annually with ...

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing ...

Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare ...

Hypertension is sometimes referred to as the "silent killer", because it usually does not exhibit any symptoms until it leads ...

This review of the nitrosamines contamination problem in pharmaceuticals takes a look at how the crisis started and developed.

Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life COMMACK, NY ...

Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life ArbliTM is ...

Another batch of medicines will be distributed across Mandaue City’s 27 barangays today, September 29, according to the City Health Office.

Scienture Holdings, Inc. (NASDAQ:SCNX) on Tuesday announced that it has formalized a commercial Pharmacy Benefit Manager (PBM) led Group Purchasing Organization (GPO) rebate agreement, advancing the ...

Scienture Holdings, Inc. (NASDAQ:SCNX) on Tuesday announced that it has formalized a commercial Pharmacy Benefit Manager (PBM) led Group Purchasing Organization (GPO) rebate agreement, advancing the ...

For the past four months my hair has been falling out. I'm taking a multivitamin but it doesn't seem to help. What can I do ...

Still, getting a corneal transplant in the developing world depends upon surgical skill and available corneas, and for the ...